The DOI matches its Crossref record; 183 of the 183 references it cites were found in a registry or an index.
A systematic review of prion therapeutics in experimental models
Abstract
Prion diseases are transmissible, invariably fatal, neurodegenerative diseases which include Creutzfeldt-Jakob disease (CJD) in humans and bovine spongiform encephalopathy and scrapie in animals. A large number of putative treatments have been studied in experimental models over the past 30 years, with at best modest disease-modifying effects. The arrival of variant CJD in the UK in the 1990s has intensified the search for effective therapeutic agents, using an increasing number of animal, cellular and in vitro models with some recent promising proof of principle studies. Here, for the first time, we present a comprehensive systematic, rather than selective, review of published data on experimental approaches to prion therapeutics to provide a scientific resource for informing future therapeutics research, both in laboratory models and in clinical studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Novel Proteinaceous Infectious Particles Cause Scrapie
Prusiner, S. B. (1982) · Science · doi:10.1126/science.6801762 · Cited by 5,118
A new variant of Creutzfeldt-Jakob disease in the UK
Will, R. G., Ironside, J. W., Zeidler, M., Estibeiro, K., Cousens, S. N., Smith, P. G., Alperovitch, A., Poser, S., Pocchiari, M., & Hofman, A. (1996) · The Lancet · doi:10.1016/s0140-6736(96)91412-9 · Cited by 2,707
Systematic Reviews in Health Care : Meta-Analysis in Context
Egger, M., Smith, G. D., & Altman, D. G. (2000) · Cited by 2,401
Mice devoid of PrP are resistant to scrapie
Büeler, H., Aguzzi, A., Sailer, A., Greiner, R.-A., Autenried, P., Aguet, M., & Weissmann, C. (1993) · Cell · doi:10.1016/0092-8674(93)90360-3 · Cited by 2,100
Transmissions to mice indicate that ‘new variant’ CJD is caused by the BSE agent
Bruce, M. E., Will, R. G., Ironside, J. W., McConnell, I., Drummond, D., Suttie, A., McCardle, L., Chree, A., Hope, J., Birkett, C., et al. (1997) · Nature · doi:10.1038/39057 · Cited by 1,967
Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD
Collinge, J., Sidle, K. C. L., Meads, J., Ironside, J., & Hill, A. F. (1996) · Nature · doi:10.1038/383685a0 · Cited by 1,735
Lim, G. P., Chu, T., Yang, F., Beech, W., Frautschy, S. A., & Cole, G. M. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-21-08370.2001 · Cited by 1,530
The same prion strain causes vCJD and BSE
Hill, A. F., Desbruslais, M., Joiner, S., Sidle, K. C. L., Gowland, I., Collinge, J., Doey, L. J., & Lantos, P. (1997) · Nature · doi:10.1038/38925 · Cited by 1,456
Systematic Reviews in Health Care. Meta-analysis in Context.
Kleijnen, J., & Antes, G. (2002) · International Journal of Epidemiology · doi:10.1093/ije/31.3.697 · Cited by 1,363
Prion Diseases of Humans and Animals: Their Causes and Molecular Basis
Collinge, J. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.519 · Cited by 1,344
Identification of a Protein That Purifies with the Scrapie Prion
Bolton, D. C., McKinley, M. P., & Prusiner, S. B. (1982) · Science · doi:10.1126/science.6815801 · Cited by 1,280
Nature of the Scrapie Agent: Self-replication and Scrapie
GRIFFITH, J. S. (1967) · Nature · doi:10.1038/2151043a0 · Cited by 1,161
Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion
Llewelyn, C., Hewitt, P., Knight, R., Amar, K., Cousens, S., Mackenzie, J., & Will, R. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15486-x · Cited by 1,128
Soto, C., Sigurdsson, E. M., Morelli, L., Asok Kumar, R., Castaño, E. M., & Frangione, B. (1998) · Nature Medicine · doi:10.1038/nm0798-822 · Cited by 876
Telling, G. C., Parchi, P., DeArmond, S. J., Cortelli, P., Montagna, P., Gabizon, R., Mastrianni, J., Lugaresi, E., Gambetti, P., & Prusiner, S. B. (1996) · Science · doi:10.1126/science.274.5295.2079 · Cited by 865
Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient
Peden, A. H., Head, M. W., Diane, L. R., Jeanne, E. B., & James, W. I. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16811-6 · Cited by 858
Telling, G. C., Scott, M., Mastrianni, J., Gabizon, R., Torchia, M., Cohen, F. E., DeArmond, S. J., & Prusiner, S. B. (1995) · Cell · doi:10.1016/0092-8674(95)90236-8 · Cited by 857
Neurodegenerative Diseases and Prions
Prusiner, S. B. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105173442006 · Cited by 772
Depleting Neuronal PrP in Prion Infection Prevents Disease and Reverses Spongiosis
Mallucci, G., Dickinson, A., Linehan, J., Klöhn, P.-C., Brandner, S., & Collinge, J. (2003) · Science · doi:10.1126/science.1090187 · Cited by 770
Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins
Kascsak, R. J., Rubenstein, R., Merz, P. A., Tonna-DeMasi, M., Fersko, R., Carp, R. I., Wisniewski, H. M., & Diringer, H. (1987) · Journal of Virology · doi:10.1128/jvi.61.12.3688-3693.1987 · Cited by 766
Shyng, S.-L., Lehmann, S., Moulder, K. L., & Harris, D. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.50.30221 · Cited by 704
Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease
Korth, C., May, B. C. H., Cohen, F. E., & Prusiner, S. B. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161274798 · Cited by 673
Bessen, R. A., & Marsh, R. F. (1994) · Journal of Virology · doi:10.1128/jvi.68.12.7859-7868.1994 · Cited by 665
Caughey, B., & Raymond, G. J. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55257-1 · Cited by 637
Transmission of the BSE Agent to Mice in the Absence of Detectable Abnormal Prion Protein
Lasmézas, C. I., Deslys, J.-P., Robain, O., Jaegly, A., Beringue, V., Peyrin, J.-M., Fournier, J.-G., Hauw, J.-J., Rossier, J., & Dormont, D. (1997) · Science · doi:10.1126/science.275.5298.402 · Cited by 582
Prion (PrPSc)-specific epitope defined by a monoclonal antibody
Korth, C., Stierli, B., Streit, P., Moser, M., Schaller, O., Fischer, R., Schulz-Schaeffer, W., Kretzschmar, H., Raeber, A., Braun, U., et al. (1997) · Nature · doi:10.1038/36337 · Cited by 567
Taraboulos, A. (1995) · The Journal of Cell Biology · doi:10.1083/jcb.129.1.121 · Cited by 543
Spontaneous Neurodegeneration in Transgenic Mice with Mutant Prion Protein
Hsiao, K. K., Scott, M., Foster, D., Groth, D. F., DeArmond, S. J., & Prusiner, S. B. (1990) · Science · doi:10.1126/science.1980379 · Cited by 530
Antibodies inhibit prion propagation and clear cell cultures of prion infectivity
Peretz, D., Williamson, R. A., Kaneko, K., Vergara, J., Leclerc, E., Schmitt-Ulms, G., Mehlhorn, I. R., Legname, G., Wormald, M. R., Rudd, P. M., et al. (2001) · Nature · doi:10.1038/35089090 · Cited by 525
Kaneko, K., Zulianello, L., Scott, M., Cooper, C. M., Wallace, A. C., James, T. L., Cohen, F. E., & Prusiner, S. B. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.19.10069 · Cited by 515
Phenolic anti-inflammatory antioxidant reversal of Aβ-induced cognitive deficits and neuropathology
Frautschy, S. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00300-1 · Cited by 514
Variant Creutzfeldt-Jakob disease
Collinge, J. (1999) · The Lancet · doi:10.1016/s0140-6736(99)05128-4 · Cited by 512
Borchelt, D. R., Scott, M., Taraboulos, A., Stahl, N., & Prusiner, S. B. (1990) · The Journal of cell biology · doi:10.1083/jcb.110.3.743 · Cited by 504
Location and properties of metal-binding sites on the human prion protein
Jackson, G. S., Murray, I., Hosszu, L. L. P., Gibbs, N., Waltho, J. P., Clarke, A. R., & Collinge, J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151038498 · Cited by 497
A crucial role for B cells in neuroinvasive scrapie
Klein, M. A., Frigg, R., Flechsig, E., Raeber, A. J., Kalinke, U., Bluethmann, H., Bootz, F., Suter, M., Zinkernagel, R. M., & Aguzzi, A. (1997) · Nature · doi:10.1038/37789 · Cited by 493
Monoclonal antibodies inhibit prion replication and delay the development of prion disease
White, A. R., Enever, P., Tayebi, M., Mushens, R., Linehan, J., Brandner, S., Anstee, D., Collinge, J., & Hawke, S. (2003) · Nature · doi:10.1038/nature01457 · Cited by 492
Preclinical variant CJD after blood transfusion in a PRNP codon 129 heterozygous patient
Peden, A., Head, M. W., Ritchie, D. L., et al. (2004) · Cited by 486
Prusiner, S. B., Groth, D., Serban, A., Koehler, R., Foster, D., Torchia, M., Burton, D., Yang, S. L., & DeArmond, S. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.22.10608 · Cited by 473
Heikenwalder, M., Polymenidou, M., Junt, T., Sigurdson, C., Wagner, H., Akira, S., Zinkernagel, R., & Aguzzi, A. (2004) · Nature Medicine · doi:10.1038/nm987 · Cited by 449
Enari, M., Flechsig, E., & Weissmann, C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151242598 · Cited by 427
The 37-kDa/67-kDa laminin receptor acts as the cell-surface receptor for the cellular prion protein
Gauczynski, S. (2001) · The EMBO Journal · doi:10.1093/emboj/20.21.5863 · Cited by 424
Mallucci, G. R., Ratté, S., Asante, E. A., Linehan, J., Gowland, I., Jefferys, J. G. R., & Collinge, J. (2002) · The EMBO Journal · doi:10.1093/emboj/21.3.202 · Cited by 393
Sulfated polyanion inhibition of scrapie-associated PrP accumulation in cultured cells
Caughey, B., & Raymond, G. J. (1993) · Journal of Virology · doi:10.1128/jvi.67.2.643-650.1993 · Cited by 392
Copper Binding in the Prion Protein
Millhauser, G. L. (2004) · Accounts of Chemical Research · doi:10.1021/ar0301678 · Cited by 392
Reversible Conversion of Monomeric Human Prion Protein Between Native and Fibrilogenic Conformations
Jackson, G. S., Hosszu, L. L. P., Power, A., Hill, A. F., Kenney, J., Saibil, H., Craven, C. J., Waltho, J. P., Clarke, A. R., & Collinge, J. (1999) · Science · doi:10.1126/science.283.5409.1935 · Cited by 364
Brown, K. L., Stewart, K., Ritchie, D. L., Mabbott, N. A., Williams, A., Fraser, H., Morrison, W. I., & Bruce, M. E. (1999) · Nature Medicine · doi:10.1038/15264 · Cited by 363
Impaired Prion Replication in Spleens of Mice Lacking Functional Follicular Dendritic Cells
Montrasio, F., Frigg, R., Glatzel, M., Klein, M. A., Mackay, F., Aguzzi, A., & Weissmann, C. (2000) · Science · doi:10.1126/science.288.5469.1257 · Cited by 357
Feraudet‐Tarisse, C., Morel, N., Simon, S., Volland, H., Frobert, Y., Créminon, C., Vilette, D., Lehmann, S., & Grassi, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407006200 · Cited by 348
Prevention of Scrapie Pathogenesis by Transgenic Expression of Anti-Prion Protein Antibodies
Heppner, F. L., Musahl, C., Arrighi, I., Klein, M. A., Rülicke, T., Oesch, B., Zinkernagel, R. M., Kalinke, U., & Aguzzi, A. (2001) · Science · doi:10.1126/science.1063093 · Cited by 346
Doh-ura, K., Iwaki, T., & Caughey, B. (2000) · Journal of Virology · doi:10.1128/jvi.74.10.4894-4897.2000 · Cited by 324
Complement facilitates early prion pathogenesis
Klein, M. A., Kaeser, P. S., Schwarz, P., Weyd, H., Xenarios, I., Zinkernagel, R. M., Carroll, M. C., Verbeek, J. S., Botto, M., Walport, M. J., et al. (2001) · Nature Medicine · doi:10.1038/86567 · Cited by 318
Culmsee, C., Zhu, X., Yu, Q.-S., Chan, S. L., Camandola, S., Guo, Z., Greig, N. H., & Mattson, M. P. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.t01-1-00220.x · Cited by 313
Porphyrin and Phthalocyanine Antiscrapie Compounds
Priola, S. A., Raines, A., & Caughey, W. S. (2000) · Science · doi:10.1126/science.287.5457.1503 · Cited by 302
Species-barrier-independent prion replication in apparently resistant species
Hill, A. F., Joiner, S., Linehan, J., Desbruslais, M., Lantos, P. L., & Collinge, J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.18.10248 · Cited by 295
Chemical chaperones interfere with the formation of scrapie prion protein.
Tatzelt, J., Prusiner, S. B., & Welch, W. J. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01027.x · Cited by 294
Identification of interaction domains of the prion protein with its 37-kDa/67-kDa laminin receptor
Hundt, C. (2001) · The EMBO Journal · doi:10.1093/emboj/20.21.5876 · Cited by 291
No propagation of prions in mice devoid of PrP
Sailer, A. (1994) · Cell · doi:10.1016/0092-8674(94)90436-7 · Cited by 285
Reversion of prion protein conformational changes by synthetic b-sheet breaker peptides
Soto, C., Kascsak, R. J., Saborío, G. P., Aucouturier, P., Wisniewski, T., Prelli, F., Kascsak, R., Mendez, E., Harris, D. A., Ironside, J., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(99)11419-3 · Cited by 274
PrP expression in B lymphocytes is not required for prion neuroinvasion
Klein, M. A., Frigg, R., Raeber, A. J., Flechsig, E., Hegyi, I., Zinkernagel, R. M., Weissmann, C., & Aguzzi, A. (1998) · Nature Medicine · doi:10.1038/4022 · Cited by 266
Elimination of prions by branched polyamines and implications for therapeutics
Supattapone, S., Nguyen, H.-O. B., Cohen, F. E., Prusiner, S. B., & Scott, M. R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.25.14529 · Cited by 259
Antibodies to a scrapie prion protein
Bendheim, P. E., Barry, R. A., DeArmond, S. J., Stites, D. P., & Prusiner, S. B. (1984) · Nature · doi:10.1038/310418a0 · Cited by 254
Büeler, H., Raeber, A., Sailer, A., Fischer, M., Aguzzi, A., & Weissmann, C. (1994) · Molecular Medicine · doi:10.1007/bf03403528 · Cited by 244
Caughey, B., Brown, K., Raymond, G. J., Katzenstein, G. E., & Thresher, W. (1994) · Journal of Virology · doi:10.1128/jvi.68.4.2135-2141.1994 · Cited by 237
Kaneko, K., Vey, M., Scott, M., Pilkuhn, S., Cohen, F. E., & Prusiner, S. B. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2333 · Cited by 236
Wong, C. '. (2001) · The EMBO Journal · doi:10.1093/emboj/20.3.377 · Cited by 235
Temporary inactivation of follicular dendritic cells delays neuroinvasion of scrapie
Mabbott, N. A., Mackay, F., Minns, F., & Bruce, M. E. (2000) · Nature Medicine · doi:10.1038/77401 · Cited by 233
Potent Inhibition of Scrapie‐Associated PrP Accumulation by Congo Red
Caughey, B., & Race, R. E. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb09437.x · Cited by 233
Kocisko, D. A., Baron, G. S., Rubenstein, R., Chen, J., Kuizon, S., & Caughey, B. (2003) · Journal of Virology · doi:10.1128/jvi.77.19.10288-10294.2003 · Cited by 231
Doh-ura, K., Ishikawa, K., Murakami-Kubo, I., Sasaki, K., Mohri, S., Race, R., & Iwaki, T. (2004) · Journal of Virology · doi:10.1128/jvi.78.10.4999-5006.2004 · Cited by 228
Horiuchi, M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.12.3193 · Cited by 226
Mabbott, N. A., Bruce, M. E., Botto, M., Walport, M. J., & Pepys, M. B. (2001) · Nature Medicine · doi:10.1038/86562 · Cited by 224
Branched Polyamines Cure Prion-Infected Neuroblastoma Cells
Supattapone, S., Wille, H., Uyechi, L., Safar, J., Tremblay, P., Szoka, F. C., Cohen, F. E., Prusiner, S. B., & Scott, M. R. (2001) · Journal of Virology · doi:10.1128/jvi.75.7.3453-3461.2001 · Cited by 221
Squalestatin 1, a potent inhibitor of squalene synthase, which lowers serum cholesterol in vivo.
Baxter, A., Fitzgerald, B. J., Hutson, J. L., McCarthy, A. D., Motteram, J. M., Ross, B. C., Sapra, M., Snowden, M. A., Watson, N. S., & Williams, R. J. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49754-8 · Cited by 208
Tetracyclines affect prion infectivity
Forloni, G., Iussich, S., Awan, T., Colombo, L., Angeretti, N., Girola, L., Bertani, I., Poli, G., Caramelli, M., Grazia Bruzzone, M., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162195499 · Cited by 208
Cordeiro, Y., Machado, F., Juliano, L., Juliano, M. A., Brentani, R. R., Foguel, D., & Silva, J. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106707200 · Cited by 208
Merlini, G., Ascari, E., Amboldi, N., Bellotti, V, Arbustini, E., Perfetti, V, Ferrari, M., Zorzoli, I., Marinone, M. G., & Garini, P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.7.2959 · Cited by 205
Fatal familial insomnia: A second kindred with mutation of prion protein gene at codon 178
Medori, R., Montagna, P., Tritschler, H. J., LeBlanc, A., Cortelli, P., Tinuper, P., Lugaresi, E., & Gambetti, P. (1992) · Neurology · doi:10.1212/wnl.42.3.669 · Cited by 204
Immunoaffinity purification and neutralization of scrapie prion infectivity.
Gabizon, R., McKinley, M. P., Groth, D., & Prusiner, S. B. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.18.6617 · Cited by 202
Deleault, N. R., Geoghegan, J. C., Nishina, K., Kascsak, R., Williamson, R. A., & Supattapone, S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503973200 · Cited by 196
Tarnopolsky, M. A., & Beal, M. F. (2001) · Annals of Neurology · doi:10.1002/ana.1028 · Cited by 195
Immunization Delays the Onset of Prion Disease in Mice
Sigurdsson, E. M., Brown, D. R., Daniels, M., Kascsak, R. J., Kascsak, R., Carp, R., Meeker, H. C., Frangione, B., & Wisniewski, T. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64151-x · Cited by 190
Copper Chelation Delays the Onset of Prion Disease
Sigurdsson, E. M., Brown, D. R., Alim, M. A., Scholtzova, H., Carp, R., Meeker, H. C., Prelli, F., Frangione, B., & Wisniewski, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c300303200 · Cited by 188
Dextran Sulphate 500 Delays and Prevents Mouse Scrapie by Impairment of Agent Replication in Spleen
Ehlers, B., & Diringer, H. (1984) · Journal of General Virology · doi:10.1099/0022-1317-65-8-1325 · Cited by 185
Rhie, A., Kirby, L., Sayer, N., Wellesley, R., Disterer, P., Sylvester, I., Gill, A., Hope, J., James, W., & Tahiri-Alaoui, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305297200 · Cited by 185
Solassol, J., Crozet, C., Perrier, V., Leclaire, J., Béranger, F., Caminade, A.-M., Meunier, B., Dormont, D., Majoral, J.-P., & Lehmann, S. (2004) · Journal of General Virology · doi:10.1099/vir.0.19726-0 · Cited by 183
Mimicking dominant negative inhibition of prion replication through structure-based drug design
Perrier, V., Wallace, A. C., Kaneko, K., Safar, J., Prusiner, S. B., & Cohen, F. E. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.11.6073 · Cited by 181
Isolation of drugs active against mammalian prions using a yeast-based screening assay
Bach, S., Talarek, N., Andrieu, T., Vierfond, J.-M., Mettey, Y., Galons, H., Dormont, D., Meijer, L., Cullin, C., & Blondel, M. (2003) · Nature Biotechnology · doi:10.1038/nbt855 · Cited by 177
Pathogenesis of Scrapie in the Mouse: the Role of the Spleen
FRASER, H., & DICKINSON, A. G. (1970) · Nature · doi:10.1038/226462a0 · Cited by 177
Effectiveness of Anthracycline Against Experimental Prion Disease in Syrian Hamsters
Tagliavini, F., McArthur, R. A., Canciani, B., Giaccone, G., Porro, M., Bugiani, M., Lievens, P. M.-J., Bugiani, O., Peri, E., Dall’Ara, P., et al. (1997) · Science · doi:10.1126/science.276.5315.1119 · Cited by 176
Tagliavini, F., Forloni, G., Colombo, L., Rossi, G., Girola, L., Canciani, B., Angeretti, N., Giampaolo, L., Peressini, E., Awan, T., et al. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.3840 · Cited by 173
Development of small molecule probes for the Beta-amyloid protein of Alzheimer's Disease
Klunk, W. E., Debnath, M. L., & Pettegrew, J. W. (1994) · Neurobiology of Aging · doi:10.1016/0197-4580(94)90050-7 · Cited by 171
Trafficking, turnover and membrane topology of PrP
Harris, D. A. (2003) · British Medical Bulletin · doi:10.1093/bmb/66.1.71 · Cited by 168
Gilch, S. (2001) · The EMBO Journal · doi:10.1093/emboj/20.15.3957 · Cited by 162
Early behavioural changes in scrapie‐affected mice and the influence of dapsone
Guenther, K. M., Deacon, R. M. J., Perry, V. H., & Rawlins, J. N. P. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01645.x · Cited by 162
Congo red prolongs the incubation period in scrapie-infected hamsters
Ingrosso, L., Ladogana, A., & Pocchiari, M. (1995) · Journal of Virology · doi:10.1128/jvi.69.1.506-508.1995 · Cited by 160
Generation of Monoclonal Antibodies against Human Prion Proteins in PrP0/0 Mice
Krasemann, S., Groschup, M. H., Harmeyer, S., Hunsmann, G., & Bodemer, W. (1996) · Molecular Medicine · doi:10.1007/bf03401656 · Cited by 159
Müller, W. E. G., Ushijima, H., Schröder, H. C., Forrest, J. M. S., Schatton, W. F. H., Rytik, P. G., & Heffner-Lauc, M. (1993) · European Journal of Pharmacology: Molecular Pharmacology · doi:10.1016/0922-4106(93)90040-g · Cited by 159
Leucht, C., Simoneau, S., Rey, C., Vana, K., Rieger, R., Lasmézas, C. I., & Weiss, S. F. T. (2003) · EMBO Reports · doi:10.1038/sj.embor.embor768 · Cited by 157
Studies of the lymphoreticular system in the pathogenesis of scrapie: The role of spleen and thymus
Fraser, H., & Dickinson, A. G. (1978) · Journal of Comparative Pathology · doi:10.1016/0021-9975(78)90010-5 · Cited by 156
Transmission of fatal familial insomnia to laboratory animals
Collinge, J., Palmer, M. S., Sidle, K. C. L., Gowland, I., Medori, R., Ironside, J. W., & Lantos, P. L. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91405-6 · Cited by 156
Dominant-negative inhibition of prion replication in transgenic mice
Perrier, V., Kaneko, K., Safar, J., Vergara, J. A., Tremblay, P., DeArmond, S. J., Cohen, F. E., Prusiner, S. B., & Wallace, A. C. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182425299 · Cited by 155
Amphotericin B treatment dissociates in vivo replication of the scrapie agent from PrP accumulation
Xi, Y. G., Ingrosso, L., Ladogana, A., Masullo, C., & Pocchiari, M. (1992) · Nature · doi:10.1038/356598a0 · Cited by 154
Mabbott, N. A., Young, J., McConnell, I., & Bruce, M. E. (2003) · Journal of Virology · doi:10.1128/jvi.77.12.6845-6854.2003 · Cited by 154
Scrapie strains maintain biological phenotypes on propagation in a cell line in culture
Birkett, C. R., Hennion, R. M., Bembridge, D. A., Clarke, M. C., Chree, A., Bruce, M. E., & Bostock, C. J. (2001) · The EMBO Journal · doi:10.1093/emboj/20.13.3351 · Cited by 153
Potent inhibition of scrapie prion replication in cultured cells by bis-acridines
May, B. C. H., Fafarman, A. T., Hong, S. B., Rogers, M., Deady, L. W., Prusiner, S. B., & Cohen, F. E. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2627988100 · Cited by 149
Marella, M., Lehmann, S., Grassi, J., & Chabry, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203248200 · Cited by 146
Glycosaminoglycans and β-amyloid, prion and tau peptides in neurodegenerative diseases
Díaz‐Nido, J., Wandosell, F. G., & Ávila, J. (2002) · Peptides · doi:10.1016/s0196-9781(02)00068-2 · Cited by 144
Klein, T. R., Kirsch, D., KAUFMANN, R. L., & Riesner, D. (1998) · Biological Chemistry · doi:10.1515/bchm.1998.379.6.655 · Cited by 143
Sulphate polyanions prolong the incubation period of scrapie-infected hamsters
Ladogana, A., Casaccia, P., Ingrosso, L., Cibati, M., Salvatore, M., Xi, Y.-G., Masullo, C., & Pocchiari, M. (1992) · Journal of General Virology · doi:10.1099/0022-1317-73-3-661 · Cited by 143
Regional heterogeneity of cellular prion protein isoforms in the mouse brain
Béringue, V. (2003) · Brain · doi:10.1093/brain/awg205 · Cited by 142
Amphotericin B Delays the Incubation Period of Scrapie in Intracerebrally Inoculated Hamsters
Pocchiari, M., Schmittinger, S., & Masullo, C. (1987) · Journal of General Virology · doi:10.1099/0022-1317-68-1-219 · Cited by 141
Gabizon, R., Meiner, Z., Halimi, M., & Ben‐Sasson, S. A. (1993) · Journal of Cellular Physiology · doi:10.1002/jcp.1041570215 · Cited by 140
Kimberlin, R. H., & Walker, C. A. (1986) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.30.3.409 · Cited by 140
New Insight into Abnormal Prion Protein Using Monoclonal Antibodies
Demart, S., Fournier, J. G., Créminon, C., Frobert, Y., Lamoury, F. M. J., Marcé, D., Lasmézas, C. I., Dormont, D., Grassi, J., & Deslys, J. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1730 · Cited by 139
Postexposure prophylaxis against prion disease with a stimulator of innate immunity.
Sethi, S., Lipford, G., Wagner, H., & Kretzschmar, H. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09513-2 · Cited by 138
Squalestatin Cures Prion-infected Neurons and Protects Against Prion Neurotoxicity
Bate, C., Salmona, M., Diomede, L., & Williams, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313061200 · Cited by 137
Farquhar, C. F., & Dickinson, A. G. (1986) · Journal of General Virology · doi:10.1099/0022-1317-67-3-463 · Cited by 135
The Tyrosine Kinase Inhibitor STI571 Induces Cellular Clearance of PrPSc in Prion-infected Cells
Ertmer, A., Gilch, S., Yun, S., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405652200 · Cited by 134
Perrier, V., Solassol, J., Crozet, C., Frobert, Y., Mourton-Gilles, C., Grassi, J., & Lehmann, S. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02356.x · Cited by 133
Congo red inhibition of scrapie agent replication
Caughey, B. W., Ernst, D. R., & Race, R. (1993) · Journal of Virology · doi:10.1128/jvi.67.10.6270-6272.1993 · Cited by 130
Soluble Dimeric Prion Protein Binds PrPSc In Vivo and Antagonizes Prion Disease
Meier, P., Genoud, N., Prinz, M., Maissen, M., Rülicke, T., Zurbriggen, A., Raeber, A. J., & Aguzzi, A. (2003) · Cell · doi:10.1016/s0092-8674(03)00201-0 · Cited by 130
Reddy, T. R. K., Mutter, R., Heal, W. P., Guo, K., Gillet, V. J., Pratt, S. D., & Chen, B. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050610f · Cited by 128
Circumventing tolerance to generate autologous monoclonal antibodies to the prion protein.
Williamson, R. A., Peretz, D., Smorodinsky, N. I., Bastidas, R. B., Serban, H., Mehlhorn, I., DeArmond, S. J., Prusiner, S. B., & Burton, D. R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.14.7279 · Cited by 128
Chemoprophylaxis of scrapie in mice
Diringer, H., & Ehlers, B. (1991) · Journal of General Virology · doi:10.1099/0022-1317-72-2-457 · Cited by 127
Mabbott, N. A., Williams, A., Farquhar, C. F., Pasparakis, M., Kollias, G., & Bruce, M. E. (2000) · Journal of Virology · doi:10.1128/jvi.74.7.3338-3344.2000 · Cited by 126
Sulfated glycosaminoglycans in amyloid plaques of prion diseases
Snow, A. D., Kisilevsky, R., Willmer, J., Prusiner, S. B., & DeArmond, S. J. (1989) · Acta Neuropathologica · doi:10.1007/bf00687367 · Cited by 124
Anti-prion antibodies for prophylaxis following prion exposure in mice
Sigurdsson, E. M., Sy, M., Li, R., Scholtzova, H., Kascsak, R. J., Kascsak, R., Carp, R., Meeker, H. C., Frangione, B., & Wısnıewskı, T. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(02)01192-8 · Cited by 122
Bacterial DNA as immune cell activator
Lipford, G. B. (1998) · Trends in Microbiology · doi:10.1016/s0966-842x(98)01408-5 · Cited by 121
Inhibition of Protease-Resistant Prion Protein Accumulation In Vitro by Curcumin
Caughey, B. W., Raymond, L. D., Raymond, G. J., Maxson, L., Silveira, J. R., & Baron, G. S. (2003) · Journal of Virology · doi:10.1128/jvi.77.9.5499-5502.2003 · Cited by 119
Mangé, A., Nishida, N., Milhavet, O., McMahon, H. E. M., Casanova, D., & Lehmann, S. (2000) · Journal of Virology · doi:10.1128/jvi.74.7.3135-3140.2000 · Cited by 115
Gilch, S., Wopfner, F., Renner‐Müller, I., Kremmer, E., Bauer, C., Wolf, E., Brem, G., Groschup, M. H., & Schätzl, H. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210723200 · Cited by 112
Failure to Demonstrate a Humoral Immune Response to Scrapie Infection in Mice
Porter, D. D., Porter, H. G., & Cox, N. A. (1973) · The Journal of Immunology · doi:10.4049/jimmunol.111.5.1407 · Cited by 106
Specific inhibition of pathological prion protein accumulation by small interfering RNAs
Daude, N., Marella, M., & Chabry, J. (2003) · Journal of Cell Science · doi:10.1242/jcs.00494 · Cited by 104
Rational targeting for prion therapeutics
Mallucci, G. R., & Collinge, J. (2004) · Nature reviews. Neuroscience · doi:10.1038/nrn1584 · Cited by 103
Mucosal vaccination delays or prevents prion infection via an oral route
Goñi, F., Knudsen, E., Schreiber, F., Scholtzova, H., Pankiewicz, J. E., Carp, R., Meeker, H. C., Rubenstein, R., Brown, D. R., Sy, M., et al. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.02.031 · Cited by 100
Potent Antiscrapie Activities of Degenerate Phosphorothioate Oligonucleotides
Kocisko, D. A., Vaillant, A., Lee, K. S., Arnold, K. M., Bertholet, N., Race, R., Olsen, E. A., Juteau, J., & Caughey, B. W. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.3.1034-1044.2006 · Cited by 98
Schwarz, A., Krätke, O., Burwinkel, M., Riemer, C., Schultz, J., Henklein, P., Bamme, T., & Baier, M. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00907-8 · Cited by 96
Copper binding to PrPC may inhibit prion disease propagation
Hijazi, N., Shaked, Y., Rosenmann, H., Ben‐Hur, T., & Gabizon, R. (2003) · Brain Research · doi:10.1016/j.brainres.2003.09.014 · Cited by 96
Quinoline Derivatives Are Therapeutic Candidates for Transmissible Spongiform Encephalopathies
Murakami-Kubo, I., Doh‐ura, K., Ishikawa, K., Kawatake, S., Sasaki, K., Kira, J., Ohta, S., & Iwaki, T. (2004) · Journal of Virology · doi:10.1128/jvi.78.3.1281-1288.2004 · Cited by 89
Kim, C.-L., Umetani, A., Matsui, T., Ishiguro, N., Shinagawa, M., & Horiuchi, M. (2004) · Virology · doi:10.1016/j.virol.2003.10.026 · Cited by 87
PrPSc Binding Antibodies Are Potent Inhibitors of Prion Replication in Cell Lines
Béringue, V., Vilette, D., Mallinson, G., Archer, F., Kaisar, M. E., Tayebi, M., Jackson, G. S., Clarke, A. R., Laude, H., Collinge, J., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402270200 · Cited by 87
Cell-surface retention of PrPC by anti-PrP antibody prevents protease-resistant PrP formation
Kim, C.-L., Karino, A., Ishiguro, N., Shinagawa, M., Sato, M., & Horiuchi, M. (2004) · Journal of General Virology · doi:10.1099/vir.0.80113-0 · Cited by 85
Protective prion protein polymorphisms against sporadic Creutzfeldt-Jakob disease
Shibuya, S., Higuchi, J., Shin, R. W., Tateishi, J., & Kitamoto, T. (1998) · The Lancet · doi:10.1016/s0140-6736(05)78358-6 · Cited by 84
Novel heparan mimetics potently inhibit the scrapie prion protein and its endocytosis
Schonberger, O., Horonchik, L., Gabizon, R., Papy-García, D., Barritault, D., & Taraboulos, A. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.10.150 · Cited by 82
Chrysamine-G, a lipophilic analogue of congo red, inhibits Aβ-induced toxicity in PC12 cells
Klunk, W. E., Debnath, M. L., Koros, A. M. C., & Pettegrew, J. W. (1998) · Life Sciences · doi:10.1016/s0024-3205(98)00454-8 · Cited by 80
Modulation of proteinase-K resistant prion protein by prion peptide immunization
Souan, L., Tal, Y., Felling, Y., Cohen, I. R., Taraboulos, A., & Mor, F. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200108)31:8<2338::aid-immu2338>3.0.co;2-v · Cited by 80
Paracrine Inhibition of Prion Propagation by Anti-PrP Single-Chain Fv Miniantibodies
Donofrío, G., Heppner, F. L., Polymenidou, M., Musahl, C., & Aguzzi, A. (2005) · Journal of Virology · doi:10.1128/jvi.79.13.8330-8338.2005 · Cited by 76
Raymond, G. J., Olsen, E. A., Lee, K. S., Raymond, L. D., Bryant, P. K., Baron, G. S., Caughey, W. S., Kocisko, D. A., McHolland, L. E., Favara, C., et al. (2005) · Journal of Virology · doi:10.1128/jvi.80.2.596-604.2006 · Cited by 75
McBride, P., Wilson, M., Eikelenboom, P., TUNSTALL, A. M., & Bruce, M. E. (1998) · Experimental Neurology · doi:10.1006/exnr.1997.6740 · Cited by 74
Cardinale, A., Filesi, I., Vetrugno, V., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407360200 · Cited by 74
In vitro cell-free conversion of bacterial recombinant PrP to PrPres as a model for conversion
Kirby, L., Birkett, C. R., Rudyk, H., Gilbert, I. H., & Hope, J. (2003) · Journal of General Virology · doi:10.1099/vir.0.18903-0 · Cited by 74
Shaked, G. M., Fridlander, G., Meiner, Z., Taraboulos, A., & Gabizon, R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.25.17981 · Cited by 67
Bertsch, U., Winklhofer, K. F., Hirschberger, T., Bieschke, J., Weber, P., Hartl, F. U., Tavan, P., Tatzelt, J., Kretzschmar, H. A., & Giese, A. (2005) · Journal of Virology · doi:10.1128/jvi.79.12.7785-7791.2005 · Cited by 66
Amphotericin B delays both scrapie agent replication and PrP-res accumulation early in infection
McKenzie, D. I., Kaczkowski, J., Marsh, R., & Aiken, J. M. (1994) · Journal of Virology · doi:10.1128/jvi.68.11.7534-7536.1994 · Cited by 62
Mabbott, N. A., McGovern, G., Jeffrey, M., & Bruce, M. E. (2002) · Journal of Virology · doi:10.1128/jvi.76.10.5131-5139.2002 · Cited by 61
Immune system and peripheral nerves in propagation of prions to CNS
Aguzzi, A., Heppner, F. L., Heikenwälder, M. F., Prinz, M., Mertz, K. D., Seeger, H., & Glatzel, M. (2003) · British Medical Bulletin · doi:10.1093/bmb/66.1.141 · Cited by 61
Efficient and specific down-regulation of prion protein expression by RNAi
Tilly, G., Chapuis, J., Vilette, D., Laude, H., & Vilotte, J.-L. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00805-2 · Cited by 59
Pharmacological studies of a new derivative of amphotericin B, MS-8209, in mouse and hamster scrapie
Demaimay, R., Adjou, K. T., Lasmézas, C. I., et al. (1994) · Journal of General Virology · doi:10.1099/0022-1317-75-9-2499 · Cited by 57
Effect of Congo Red on Wild‐Type and Mutated Prion Proteins in Cultured Cells
Milhavet, O., Mangé, A., Casanova, D., & Lehmann, S. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0740222.x · Cited by 55
Inhibition of scrapie-associated PrP accumulation
Priola, S. A., & Caughey, B. W. (1994) · Molecular Neurobiology · doi:10.1007/bf02780661 · Cited by 55
Copper (II) ions potently inhibit purified PrPres amplification
Orem, N. R., Geoghegan, J. C., Deleault, N. R., Kascsak, R. J., & Supattapone, S. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03650.x · Cited by 55
Kocisko, D. A., Engel, A. L., Harbuck, K., Arnold, K. M., Olsen, E. A., Raymond, L. D., Vilette, D., & Caughey, B. W. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.06.053 · Cited by 54
Magri, G., Clerici, M., Dall’Ara, P., Biasin, M., Caramelli, M., Casalone, C., Giannino, M. L., Longhi, R., Piacentini, L., Bella, S. D., et al. (2005) · Vaccine · doi:10.1016/j.vaccine.2004.11.067 · Cited by 53
Protein Conformation Significantly Influences Immune Responses to Prion Protein
Khalili-Shirazi, A., Quaratino, S., Londei, M., Summers, L. E., Tayebi, M., Clarke, A. R., Hawke, S. H., Jackson, G. S., & Collinge, J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.6.3256 · Cited by 49
Dapsone to delay symptoms in Creutzfeldt-Jakob disease
Manuelidis, L., Fritch, W., & Zaitsev, I. V. (1998) · The Lancet · doi:10.1016/s0140-6736(05)79191-1 · Cited by 49
A Porphyrin Increases Survival Time of Mice after Intracerebral Prion Infection
Kocisko, D. A., Caughey, W. S., Race, R., Roper, G., Caughey, B. W., & Morrey, J. D. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.2.759-761.2006 · Cited by 47
KDEL-tagged anti-prion intrabodies impair PrP lysosomal degradation and inhibit scrapie infectivity
Vetrugno, V., Cardinale, A., Filesi, I., et al. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.10.146 · Cited by 46
Kocisko, D. A., Morrey, J. D., Race, R., Chen, J., & Caughey, B. W. (2004) · Journal of General Virology · doi:10.1099/vir.0.80082-0 · Cited by 45
EFFECT OF A SINGLE DOSE OF DIMETHYL SULPHOXIDE ON RENAL AMYLOIDOSIS
Ravid, M., Kedar, I., & SOHAR, E. (1977) · The Lancet · doi:10.1016/s0140-6736(77)92171-7 · Cited by 41
Complete Freund's adjuvant immunization prolongs survival in experimental prion disease in mice
Tal, Y., Souan, L., Cohen, I. R., Meiner, Z., Taraboulos, A., & Mor, F. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10474 · Cited by 41
Mefloquine, an Antimalaria Drug with Antiprion Activity In Vitro, Lacks Activity In Vivo
Kocisko, D. A., & Caughey, B. W. (2005) · Journal of Virology · doi:10.1128/jvi.80.2.1044-1046.2006 · Cited by 38
Variant Creutzfeldt-Jakob disease
Turner, M. J., & Ludlam, C. A. (2000) · Transfusion Medicine Reviews · doi:10.1053/tm.2000.7357 · Cited by 33
Miyamoto, K., Nakamura, N., Aosasa, M., Nishida, N., Yokoyama, T., Horiuchi, H., Furusawa, S., & Matsuda, H. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.07.063 · Cited by 30
Cyclo-oxygenase inhibitors protect against prion-induced neurotoxicity in vitro
Bate, C., Rutherford, S., Gravenor, M., Reid, S. W. J., & Williams, A. (2002) · Neuroreport · doi:10.1097/00001756-200210280-00021 · Cited by 29
Failure of Interferon to Modify Scrapie in the Mouse
Field, E. J., Joyce, G., & Keith, A. B. (1969) · Journal of General Virology · doi:10.1099/0022-1317-5-1-149 · Cited by 27
Borchelt, D., Scott, M. J., Taraboulos, A., et al. (1990) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199005000-00156 · Cited by 26
Nordström, E. K., Luhr, K. M., Ibáñez, C. F., & Kristensson, K. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.2349-05.2005 · Cited by 25
Kishida, H., Sakasegawa, Y., Watanabe, K., Yamakawa, Y., Nishijima, M., Kuroiwa, Y., Hachiya, N., & Kaneko, K. (2004) · Amyloid · doi:10.1080/13506120410001689634 · Cited by 20
Influence of aminasine on experimental scrapie in mice.
Vm, R., Fokina, G. I., & Pogodina, V. V. (1984) · PubMed · Cited by 18
Failure to Modify Scrapie in Mice by Administration of Interferon or Anti-interferon Globulin
Gresser, I., Maury, C., & Chandler, R. L. (1983) · Journal of General Virology · doi:10.1099/0022-1317-64-6-1387 · Cited by 18
Evaluation of Anti-Prionic Activity of Clioquinol in an in vivo Model (Mesocricetus auratus)
Pollera, C., Lucchini, B., Formentin, E. A. M., Bareggi, S. R., Poli, G., & Ponti, W. (2005) · Veterinary Research Communications · doi:10.1007/s11259-005-0055-8 · Cited by 14
Generation of Antibodies Against Prion Protein by Scrapie-Infected Cell Immunization of PrP 0/0 Mice
Nakamura, N., Miyamoto, K., Shimokawa, M., Nishida, N., Mohri, S., Kitamoto, T., Horiuchi, H., Furusawa, S., & Matsuda, H. (2003) · Hybridoma and Hybridomics · doi:10.1089/153685903322328992 · Cited by 13
Prion (PrPSc)-Specific epitope defined by a monoclonal antibody
(1998) · Transfusion Medicine Reviews · doi:10.1016/s0887-7963(98)80077-1 · Cited by 11
Cited by
Protein aggregation diseases: pathogenicity and therapeutic perspectives
Aguzzi, A., & O'Connor, T. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3050 · Cited by 762
Rutin as a Potent Antioxidant: Implications for Neurodegenerative Disorders
Enogieru, A. B., Haylett, W., Hiss, D. C., Bardien, S., & Ekpo, O. E. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/6241017 · Cited by 476
Colby, D. W., & Prusiner, S. B. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a006833 · Cited by 472
Wagner, J., Ryazanov, S., Leonov, A., Levin, J., Shi, S., Schmidt, F., Prix, C., Pan-Montojo, F., Bertsch, U., Mitteregger-Kretzschmar, G., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1114-9 · Cited by 457
Atarashi, R., Moore, R. A., Sim, V. L., Hughson, A. G., Dorward, D. W., Onwubiko, H. A., Priola, S. A., & Caughey, B. (2007) · Nature Methods · doi:10.1038/nmeth1066 · Cited by 350
Metadata
- Authors
- Trevitt, C. R.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-09-01
- Volume
- 129
- Issue
- 9
- Pages
- 2241-2265
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2082998566
- Cited by
- 263
- References
- 183
- FWCI
- 1.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.